In the area for medical professionals, you can find current information about products and study summaries for individual topics. You can either sign up using the AOP Orphan Account Service (create a personal account with a password) or log in using your DocCheck password.
Tetmodis (Tetrabenazine) is used as symptomatic therapy in the treatment of hyperkinetic motor disorders in Huntington’s disease. Tetrabenazine is also used in etiologies such as tardive dyskinesia, tics and dystonia.
AOP Orphan uses cookies to make its website more user-friendly, effective and secure. By using this site you agree to the use of cookies. For more information on cookie usage and how to block them please visit the privacy section of the website.
